- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05199935
Testing the Effectiveness of a Safety-promoting Intervention in Antenatal Care
January 20, 2026 updated by: Norwegian University of Science and Technology
A Randomized Controlled Trial Comparing the Effectiveness of a Safety-promoting Intervention With Standard Antenatal Care for Pregnant Women in Nepal
Domestic violence during pregnancy can directly or indirectly cause maternal and fetal morbidity and even mortality.
The investigators have validated the Abuse Assessment Screen to the Nepali context for use with a color-coded audio computer assisted self-interview method among pregnant women.
This instrument will be used to identify women experiencing domestic violence during or shortly prior to their current pregnancy.
In addition, an intervention video was developed.
The aim of the video is to encourage women to take safety actions, in particular telling someone about the violence experienced.
Women in the control group will watch a video on a healthy pregnancy and sign and symptoms of complications and what to to if these occur.The control video was chosen to increase blinding.
This study aims to investigate the effect of the video compared to an intervention video.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled study is a two armed study, which will take place at two locations in Nepal.
Eligible women will be invited to the study when attending routine antenatal care.
Women agreeing to participate will be invited to first complete a questionnaire.
Upon completion of this first questionnaire women will view either the intervention or control video, irrespective of their Domestic Violence (DV) Status.
In the intervention arm all women will be shown the intervention video, irrespective of their DV status.
In the control arm women view an intervention video.
All women are asked to return to the study during the last two months of their pregnancy.
All women will be asked to complete the second questionnaire.
Upon completions all women will be offered to see the intervention video.
For the intervention group this will be their second viewing, for the control group this will be the first viewing of the intervention video.
All women will be followed up til birth.
Data about their birth will be collected from their hospital records.
Study Type
Interventional
Enrollment (Actual)
2230
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dhulikhel, Nepal
- Dhulikhel Hospital
-
Kathmandu, Nepal
- Kathmandu Medical College
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- between 12 to 20 weeks gestational age of pregnancy
Exclusion Criteria:
- prior 12 weeks gestation
- after 20 weeks of pregnancy
- mentally unable to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Are shown the intervention video after filling out baseline questionnaire
|
Information on violence and safety behaviors.
Women are encouraged to share their experience of domestic violence with others.
|
|
Other: Control
Are shown a control at Time 0, baseline and the intervention video after main outcome data is collected at Time 1
|
Control video on healthy pregnancy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Seeking support
Time Frame: 12 to 24 weeks after intervention
|
A single question asking women if they have told anybody about the experience of domestic violence besides the person at the personal follow-up at Time 1 (baseline)
|
12 to 24 weeks after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ways of Coping Checklist
Time Frame: 12 to 24 weeks after intervention
|
Sub-scales seeking social support, avoidance and detachment, self-blame
|
12 to 24 weeks after intervention
|
|
Use of safety measures
Time Frame: 12 to 24 weeks after intervention
|
Measures women can take to prepare for leaving or reduce violence
|
12 to 24 weeks after intervention
|
|
Change in Domestic Violence status
Time Frame: From baseline (questionnaire nr. 1) to time 1, questionnaire number 2.
|
A change in domestic violence status from reporting not any experience of any domestic violence to reporting experience of any domestic violence, or the contrasting result going from reporting the experience of any domestic violence to reporting no experience of any domestic violence.
|
From baseline (questionnaire nr. 1) to time 1, questionnaire number 2.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hopkins Symptom Checklist - 10
Time Frame: 12 to 24 weeks after intervention
|
Symptoms of depression and anxiety
|
12 to 24 weeks after intervention
|
|
Social Acceptance of Wife Abuse Scale
Time Frame: 12 to 24 weeks after intervention
|
6 items from the Social Acceptance of Wife Abuse Scale (SAWAS).
Minimum score is 0 (zero) and maximum score is 3.
A higher score is a worse outcome.
|
12 to 24 weeks after intervention
|
|
Attitudes towards domestic violence
Time Frame: 12 to 24 weeks after intervention
|
WHO set of questions
|
12 to 24 weeks after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Schei Berit, PhD, Norwegian University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 29, 2023
Primary Completion (Actual)
October 1, 2025
Study Completion (Actual)
October 1, 2025
Study Registration Dates
First Submitted
January 5, 2022
First Submitted That Met QC Criteria
January 19, 2022
First Posted (Actual)
January 20, 2022
Study Record Updates
Last Update Posted (Actual)
January 22, 2026
Last Update Submitted That Met QC Criteria
January 20, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 178092
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Domestic Violence
-
University of the Virgin IslandsUnknownDomestic Violence | Domestic AbuseVirgin Islands (U.S.)
-
Medical Research Council, South AfricaUniversity of GhanaUnknownSexual Violence | Domestic Violence | Physical ViolenceGhana
-
Johns Hopkins UniversityUniversity of Pittsburgh; Office of Research on Women's Health (ORWH); Futures...CompletedViolence, Domestic | Violence, SexualUnited States
-
Funmilola OlaOlorunUniversity of IbadanCompletedDomestic Violence | Violence | AttitudeNigeria
-
Karolinska InstitutetRegion Stockholm; Jane and Dan Olsson Foundation for Scientific PurposesCompletedDomestic Violence | Family Violence | Intimate-partner ViolenceSweden
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDomestic Violence | Intimate Partner ViolenceUnited States
-
NMP Medical Research InstituteWarwick Research Services; Arsha Vidya Study Centre, Tamilnadu, IndiaCompletedDomestic Violence | Intimate Partner ViolenceIndia
-
University of UtahCompletedDomestic Violence | Intimate Partner ViolenceUnited States
-
University of PittsburghCompletedViolence in Adolescence | Domestic ViolenceUnited States
-
University of SheffieldUniversity of HuddersfieldCompleted
Clinical Trials on Video
-
King's College LondonRecruitingCannabis UserUnited Kingdom
-
University of California, DavisRecruitingCancer Prevention | FirefightersUnited States
-
National Development and Research Institutes, Inc.UnknownHIV TestingUnited States
-
Medical College of WisconsinCompleted
-
University of Auckland, New ZealandNot yet recruitingHyperthyroidism | Thyroid Cancer | Radioiodine Treatment
-
Massachusetts General HospitalFoundation for Informed Medical Decision MakingCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Active, not recruitingDepression | Anxiety | Mobile Phone Use | Health Knowledge, Attitudes, Practice | StigmatizationUnited States
-
Wolfson Medical CenterRecruitingInduction of Labor Affected Fetus / NewbornIsrael